1. Home
  2. HRMY
  3. HRMY News

Latest Harmony Biosciences Holdings Inc. (HRMY) News on November 17, 2024

HRMY

Argus Research

5 days ago

HRMY: Rating increased to a BUY

HRMY

Argus Research

12 days ago

HRMY: Lowering target price to $35.00

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings
HRMY

Simply Wall St.

12 days ago

There May Be Some Bright Spots In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
HRMY

Simply Wall St.

16 days ago

Earnings Beat: Harmony Biosciences Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
HRMY

Zacks

16 days ago

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

HRMY vs. REGN: Which Stock Is the Better Value Option?
HRMY

Zacks

17 days ago

HRMY vs. REGN: Which Stock Is the Better Value Option?

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations
HRMY

Simply Wall St.

17 days ago

Harmony Biosciences Holdings Third Quarter 2024 Earnings: Beats Expectations

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders
HRMY

PR Newswire

18 days ago

Harmony Biosciences Holdings, Inc. Announces Pricing of Public Offering of Common Stock by Selling Shareholders

HRMY

MT Newswires

18 days ago

Harmony Biosciences Holdings Launches Secondary Common Stock Offering

Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...
HRMY

GuruFocus.com

18 days ago

Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth ...

HRMY

Thomson Reuters StreetEvents

18 days ago

Q3 2024 Harmony Biosciences Holdings Inc Earnings Call

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders
HRMY

PR Newswire

19 days ago

Harmony Biosciences Holdings, Inc. Announces Commencement of Proposed Public Offering of Common Stock by Selling Shareholders

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat
HRMY

Investor's Business Daily

19 days ago

Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat

Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript
HRMY

Motley Fool

19 days ago

Harmony Biosciences (HRMY) Q3 2024 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates
HRMY

Zacks

19 days ago

Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings and Revenues Surpass Estimates

HRMY

MT Newswires

19 days ago

Harmony Biosciences Holdings Q3 Adjusted Earnings, Net Product Revenue Increase

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS
HRMY

PR Newswire

19 days ago

HARMONY BIOSCIENCES REPORTS STRONG THIRD QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS CATALYST-RICH, LATE-STAGE PIPELINE POISED TO DELIVER ONE OR MORE NEW LAUNCHES EVERY YEAR OVER NEXT FIVE YEARS

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
HRMY

Zacks

25 days ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?
HRMY

Zacks

a month ago

Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: Should You Buy?

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024
HRMY

PR Newswire

a month ago

HARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024

Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth
HRMY

Insider Monkey

a month ago

Wall Street Analysts Favor Harmony Biosciences Holdings, Inc. (HRMY) for Growth

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?
HRMY

Insider Monkey

a month ago

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving Technical Ratings According To Piper Sandler?

Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...
HRMY

GuruFocus.com

a month ago

Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong Revenue Growth ...

HRMY

Argus Research

a month ago

HRMY: Lowering target price to $36.00

HRMY

Investing.com

a month ago

Mizuho adds 2 new stocks to its Top Picks list

HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY
HRMY

PR Newswire

2 months ago

HARMONY BIOSCIENCES HIGHLIGHTS NEW DATA, ROBUST LATE-STAGE PIPELINE WITH NEAR-TERM VALUE CREATION OPPORTUNITIES AND ITS BOLD NEW VISION AT INVESTOR DAY

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?
HRMY

Insider Monkey

2 months ago

Is Harmony Biosciences Holdings, Inc. (HRMY) the Best Cheap Growth Stock to Buy According to Analysts?

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?
HRMY

Zacks

2 months ago

Harmony Biosciences (HRMY) Surges 6.7%: Is This an Indication of Further Gains?

HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024
HRMY

PR Newswire

2 months ago

HARMONY BIOSCIENCES TO HOST FIRST INVESTOR DAY ON OCTOBER 1, 2024

Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
HRMY

Zacks

2 months ago

Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?

Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know
HRMY

Zacks

2 months ago

Harmony Biosciences (HRMY) Upgraded to Buy: Here's What You Should Know

HRMY vs. REGN: Which Stock Should Value Investors Buy Now?
HRMY

Zacks

2 months ago

HRMY vs. REGN: Which Stock Should Value Investors Buy Now?

Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish
HRMY

Insider Monkey

2 months ago

Harmony Biosciences Holdings, Inc. (HRMY): Short Seller Sentiment is Bearish

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says
HRMY

Benzinga

2 months ago

Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says

HRMY

MT Newswires

2 months ago

Harmony Biosciences Boosted by Narcolepsy Treatment, Diversification Outlook. UBS Says

HRMY

MT Newswires

2 months ago

UBS Initiates Harmony Biosciences Holdings at Buy With $56 Price Target

HRMY

Argus Research

3 months ago

HRMY: Lowering target price to $37.00

HRMY or REGN: Which Is the Better Value Stock Right Now?
HRMY

Zacks

3 months ago

HRMY or REGN: Which Is the Better Value Stock Right Now?

Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?
HRMY

Zacks

3 months ago

Is Harmony Biosciences (HRMY) a Great Value Stock Right Now?

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HRMY

PR Newswire

3 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

HRMY

Argus Research

3 months ago

HRMY: Raising target price to $38.00

Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock
HRMY

Zacks

3 months ago

Surging Earnings Estimates Signal Upside for Harmony Biosciences (HRMY) Stock

Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?
HRMY

Zacks

3 months ago

Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?

HRMY vs. REGN: Which Stock Is the Better Value Option?
HRMY

Zacks

3 months ago

HRMY vs. REGN: Which Stock Is the Better Value Option?

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?
HRMY

Zacks

3 months ago

Should Value Investors Buy Harmony Biosciences (HRMY) Stock?

Harmony Biosciences Holdings Second Quarter 2024 Earnings: EPS Beats Expectations
HRMY

Simply Wall St.

3 months ago

Harmony Biosciences Holdings Second Quarter 2024 Earnings: EPS Beats Expectations

HRMY

MT Newswires

3 months ago

Mizuho Securities Adjusts Harmony Biosciences Price Target to $42 From $40, Maintains Outperform Rating

Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript
HRMY

Motley Fool

3 months ago

Harmony Biosciences (HRMY) Q2 2024 Earnings Call Transcript

HRMY

MT Newswires

3 months ago

Harmony Biosciences' Q2 Adjusted EPS, Revenue Rise; Shares Gain

Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates
HRMY

Zacks

3 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Surpasses Q2 Earnings and Revenue Estimates

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
HRMY

GlobeNewswire

3 months ago

Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals?
HRMY

Simply Wall St.

4 months ago

Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock Is Going Strong: Is the Market Following Fundamentals?

HRMY

Argus Research

4 months ago

HRMY: Lowering target price to $35.00

HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024
HRMY

PR Newswire

4 months ago

HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

HRMY or REGN: Which Is the Better Value Stock Right Now?
HRMY

Zacks

4 months ago

HRMY or REGN: Which Is the Better Value Stock Right Now?

Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?
HRMY

Zacks

4 months ago

Wall Street Analysts See a 32.82% Upside in Harmony Biosciences (HRMY): Can the Stock Really Move This High?

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?
HRMY

Zacks

4 months ago

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

HRMY

Argus Research

4 months ago

HRMY: What does Argus have to say about HRMY?

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?
HRMY

Zacks

4 months ago

MannKind Corporation (MNKD) Hit a 52 Week High, Can the Run Continue?

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?
HRMY

Zacks

4 months ago

Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?

HRMY

Argus Research

4 months ago

HRMY: Raising target price to $36.00

5 High Earnings Yield Value Stocks That You Shouldn't Ignore
HRMY

Zacks

4 months ago

5 High Earnings Yield Value Stocks That You Shouldn't Ignore

HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
HRMY

PR Newswire

5 months ago

HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)

HRMY

MT Newswires

5 months ago

Harmony Biosciences Says FDA Approves Supplemental NDA for Pediatric Narcolepsy Treatment

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX® (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY
HRMY

PR Newswire

5 months ago

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX® (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY

HRMY

MT Newswires

5 months ago

Citigroup Initiates Harmony Biosciences at Buy Rating With $48 Price Target

Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
HRMY

Zacks

5 months ago

Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1
HRMY

PR Newswire

5 months ago

HARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1

HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE
HRMY

PR Newswire

6 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCE

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
HRMY

Simply Wall St.

6 months ago

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations
HRMY

Simply Wall St.

6 months ago

Harmony Biosciences Holdings First Quarter 2024 Earnings: EPS Beats Expectations

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice
HRMY

Zacks

7 months ago

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

HRMY or TECH: Which Is the Better Value Stock Right Now?
HRMY

Zacks

7 months ago

HRMY or TECH: Which Is the Better Value Stock Right Now?

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
HRMY

Insider Monkey

7 months ago

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript

Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript
HRMY

Motley Fool

7 months ago

Harmony Biosciences (HRMY) Q1 2024 Earnings Call Transcript

Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View
HRMY

Benzinga

7 months ago

Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View

HRMY

MT Newswires

7 months ago

Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise

Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024
HRMY

GuruFocus.com

7 months ago

Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
HRMY

GlobeNewswire

7 months ago

Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets
HRMY

PR Newswire

7 months ago

Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS Assets

HRMY

Argus Research

7 months ago

HRMY: Lowering target price to $30.00

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024
HRMY

PR Newswire

7 months ago

HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST
HRMY

PR Newswire

7 months ago

HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME
HRMY

PR Newswire

7 months ago

HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
HRMY

PR Newswire

8 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares
HRMY

GuruFocus.com

8 months ago

Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares

10 Biotech Stocks with Huge Potential
HRMY

Insider Monkey

8 months ago

10 Biotech Stocks with Huge Potential

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
HRMY

PR Newswire

9 months ago

HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript
HRMY

Insider Monkey

9 months ago

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript

HRMY vs. TECH: Which Stock Is the Better Value Option?
HRMY

Zacks

9 months ago

HRMY vs. TECH: Which Stock Is the Better Value Option?

HRMY

Thomson Reuters StreetEvents

9 months ago

Q4 2023 Harmony Biosciences Holdings Inc Earnings Call

Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
HRMY

Motley Fool

9 months ago

Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates
HRMY

Zacks

9 months ago

Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates

Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023
HRMY

GuruFocus.com

9 months ago

Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023

Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
HRMY

GlobeNewswire

9 months ago

Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
HRMY

PR Newswire

9 months ago

U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME
HRMY

PR Newswire

9 months ago

HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME

The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
HRMY

InvestorPlace

9 months ago

The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024

HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024
HRMY

PR Newswire

9 months ago

HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024

The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
HRMY

InvestorPlace

9 months ago

The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024

Share on Social Networks: